Cardiac Arrhythmia in Patients With End-Stage Renal Disease
NCT: NCT04841304 · COMPLETED
Brief Summary
The study will examine the presence of cardiac arrhythmias in patients receiving hemodialysis and the role of diabetes, hypoglycemia and parameters related to uremia and the dialysis procedure. The study is designed as a prospective cohort study with 18 months follow-up. 70 patients receiving chronic hemodialysis will be recruited and equipped with implantable loop recorders (ILR): 35 patients with diabetes and 35 patients without diabetes. Data collection during the follow-up includes continuous monitoring of the heart rhythm by the ILR for the entire follow-up period, continuous glucose monitoring for 10 days every second month, and monthly collection of blood samples and dialytic parameters. After the initial 18-month follow-up, heart rhythm monitoring will continue until the ILR battery runs out for those participants who wish to continue.
Frequently Asked Questions
What is Cardiac Arrhythmia in Patients With End-Stage Renal Disease?
Cardiac Arrhythmia in Patients With End-Stage Renal Disease is a clinical trial registered under NCT04841304. Current status: COMPLETED.
What is the status of NCT04841304?
The current status of NCT04841304 (Cardiac Arrhythmia in Patients With End-Stage Renal Disease) is: COMPLETED.
When did Cardiac Arrhythmia in Patients With End-Stage Renal Disease start?
Cardiac Arrhythmia in Patients With End-Stage Renal Disease started on 2021-06-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.